COVID-19 and Panax ginseng: Targeting platelet aggregation, thrombosis and the coagulation pathway.
Ontology highlight
ABSTRACT: Coronavirus disease 2019 (COVID-19) not only targets the respiratory system but also triggers a cytokine storm and a series of complications, such as gastrointestinal problems, acute kidney injury, and myocardial ischemia. The use of natural products has been utilized to ease the symptoms of COVID-19, and in some cases, to strengthen the immune system against COVID-19. Natural products are readily available and have been regularly consumed for various health benefits. COVID-19 has been reported to be associated with the risk of thromboembolism and deep vein thrombosis. These thrombotic complications often affects mortality and morbidity. Panax ginseng, which has been widely consumed for its various health benefits has also been reported for its therapeutic effects against cardiovasc
SUBMITTER: Lee YY
PROVIDER: S-EPMC8767971 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA